CaltechAUTHORS
  A Caltech Library Service

Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design

Diskin, Ron and Scheid, Johannes F. and Marcovecchio, Paola M. and West, Anthony P., Jr. and Klein, Florian and Gao, Han and Gnanapragasam, Priyanthi N. P. and Abadir, Alexander and Seaman, Michael S. and Nussenzweig, Michel C. and Bjorkman, Pamela J. (2011) Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design. Science, 334 (6060). pp. 1289-1293. ISSN 0036-8075. PMCID PMC3232316. https://resolver.caltech.edu/CaltechAUTHORS:20111220-092937610

[img] PDF - Accepted Version
See Usage Policy.

3997Kb
[img]
Preview
PDF - Supplemental Material
See Usage Policy.

7Mb

Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:20111220-092937610

Abstract

Antibodies against the CD4 binding site (CD4bs) on the HIV-1 spike protein gp120 can show exceptional potency and breadth. We determined structures of NIH45-46, a more potent clonal variant of VRC01, alone and bound to gp120. Comparisons with VRC01-gp120 revealed that a four-residue insertion in heavy chain complementarity–determining region 3 (CDRH3) contributed to increased interaction between NIH45-46 and the gp120 inner domain, which correlated with enhanced neutralization. We used structure-based design to create NIH45-46^(G54W), a single substitution in CDRH2 that increases contact with the gp120 bridging sheet and improves breadth and potency, critical properties for potential clinical use, by an order of magnitude. Together with the NIH45-46–gp120 structure, these results indicate that gp120 inner domain and bridging sheet residues should be included in immunogens to elicit CD4bs antibodies.


Item Type:Article
Related URLs:
URLURL TypeDescription
http://dx.doi.org/10.1126/science.1213782DOIArticle
http://www.sciencemag.org/content/334/6060/1289.abstractPublisherArticle
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232316/PubMed CentralArticle
ORCID:
AuthorORCID
Diskin, Ron0000-0002-2837-5897
Nussenzweig, Michel C.0000-0003-0592-8564
Bjorkman, Pamela J.0000-0002-2277-3990
Additional Information:© 2011 American Association for the Advancement of Science. Received for publication 9 September 2011. Accepted for publication 18 October 2011. We thank B. Hahn, J. Baalwa, F. McCutchan, G. Shaw, D. Montefiori, M. Thomson, J. Overbaugh, R. Swanstrom, L. Morris, J. Kim, L. Zhang, D. Ellenberger, and C. Williamson for contributing the HIV-1 envelope plasmids used in our neutralization panel; the Caltech Protein Expression Center; T. Oliveira and A. Halper-Stromberg for calculations and helpful discussions; and members of the Bjorkman and Nussenzweig laboratories for critical reading of the manuscript. R.D., J.F.S., M.C.N., and P.J.B. have pending patent applications with the U.S. Patent and Trademark Office, patent numbers U.S. 61/486,960 and 61/523,244, titled “Human immunodeficiency virus neutralizing antibodies and methods of use thereof” and “Anti-HIV antibodies and related methods and compositions,” respectively. The reagents are available with a Materials Transfer Agreement. This work was supported by Collaboration for AIDS Vaccine Discovery (CAVD) grants with support from the Bill and Melinda Gates Foundation [grant 38660 (P.J.B.), grant 38619 (M.S.S.) and grant 38619s (M.C.N.)]; NIH grants P01 AI081677-01 (M.C.N.), RR00862, and RR022220; and the Molecular Observatory at Caltech, supported by the Gordon and Betty Moore Foundation and the Sanofi-Aventis Bioengineering Research Program. F.K. was supported by the German Research Foundation (DFG, KL 2389/1-1). Operations at Stanford Synchrotron Radiation Lightsource are supported by the U.S. Department of Energy and NIH. The data reported in this paper are tabulated in the main text and the supporting online material, and coordinates and x-ray crystallographic data for the NIH45-46–gp120 complex and NIH45-46 Fab have been deposited in the PDB (accession codes 3U7Y and 3U7W, respectively).
Funders:
Funding AgencyGrant Number
Collaboration for AIDS Vaccine DiscoveryUNSPECIFIED
Bill and Melinda Gates Foundation38660
Bill and Melinda Gates Foundation38619
Bill and Melinda Gates Foundation38619s
NIHP01 AI081677-01
NIHRR00862
NIHRR022220
Caltech Molecular ObservatoryUNSPECIFIED
Gordon and Betty Moore FoundationUNSPECIFIED
Sanofi-Aventis Bioengineering Research ProgramUNSPECIFIED
Deutsche Forschungsgemeinschaft (DFG)KL 2389/1-1
Department of Energy (DOE)UNSPECIFIED
Issue or Number:6060
PubMed Central ID:PMC3232316
Record Number:CaltechAUTHORS:20111220-092937610
Persistent URL:https://resolver.caltech.edu/CaltechAUTHORS:20111220-092937610
Official Citation:Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design Ron Diskin, Johannes F. Scheid, Paola M. Marcovecchio, Anthony P. West Jr., Florian Klein, Han Gao, Priyanthi N. P. Gnanapragasam, Alexander Abadir, Michael S. Seaman, Michel C. Nussenzweig, and Pamela J. Bjorkman Science 2 December 2011: 1289-1293. Published online 27 October 2011 [DOI:10.1126/science.1213782]
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:28529
Collection:CaltechAUTHORS
Deposited By: Ruth Sustaita
Deposited On:20 Dec 2011 18:18
Last Modified:03 Oct 2019 03:33

Repository Staff Only: item control page